We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The characteristics, management and surveillance of Gram-negative bacteria such as Escherichia coli, Klebsiella and Pseudomonas aeruginosa.
BRD is a national and international laboratory reference centre for a wide range of bacterial infections.
Form (R3) for identification of Haemophilus influenzae, Streptococcus pneumoniae, bordetella, diphtheria and tetanus.
Form L5 for identification of Clostridium botulinum, Clostridium perfringens, Clostridium tetani, Escherichia coli, helicobacter, listeria and yersinia.
Form L7 for the isolation, identification and toxin detection of clostridium botulinum and Staphylococcus aureus.
GBRU is the national reference laboratory for gastrointestinal pathogens and provides specialist testing of clinical, food, water and environmental samples.
Respiratory and vaccine preventable bacteria reference unit (RVPBRU), provides national and international reference laboratory services.
Form L4 for identification of bacillus, C. botulinum, C. perfringens, C. tetani, campylobacter, E. coli, helicobacter, listeria, salmonella, shigella, vibrio and yersinia.
Animal bites and pasteurella infections information for healthcare staff.
Quarterly reports on acquired carbapenemase-producing Gram-negative bacteria identified in human samples in England.
This consultation asks for feedback on UK SMI ID 1: Introduction to the preliminary identification of medically important bacteria and fungi from culture.
The diversity of microorganisms remains largely untapped
Form M1 for submitting single isolates to bacterial identification section (BIDS).
The characteristics, diagnosis, management, surveillance and epidemiology of Staphylococcus aureus.
An assessment of the risk that newly emerging tick-borne bacteria present to the UK population.
Antibiotic resistance is once again on the rise after declines in the pandemic, with more dangerous strains of bacteria spreading in communities and hospitals.
The symptoms, diagnosis, management and epidemiology of campylobacter.
How DNA sequencing could be used to detect and identify probiotic bacteria and the benefits this approach provides.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.